HRP20171944T1 - Oralno otapajući filmovi - Google Patents
Oralno otapajući filmovi Download PDFInfo
- Publication number
- HRP20171944T1 HRP20171944T1 HRP20171944TT HRP20171944T HRP20171944T1 HR P20171944 T1 HRP20171944 T1 HR P20171944T1 HR P20171944T T HRP20171944T T HR P20171944TT HR P20171944 T HRP20171944 T HR P20171944T HR P20171944 T1 HRP20171944 T1 HR P20171944T1
- Authority
- HR
- Croatia
- Prior art keywords
- film
- polymer
- nicotine
- neutralizing agent
- potassium
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 230000003472 neutralizing effect Effects 0.000 claims 6
- 229960002715 nicotine Drugs 0.000 claims 6
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims 6
- -1 poly(ethylacrylate-methacrylic acid) copolymer Polymers 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 229920002959 polymer blend Polymers 0.000 claims 4
- 229920006254 polymer film Polymers 0.000 claims 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- 239000000872 buffer Substances 0.000 claims 2
- 238000005266 casting Methods 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 239000000945 filler Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- 229940111685 dibasic potassium phosphate Drugs 0.000 claims 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 claims 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims 1
- 239000001095 magnesium carbonate Substances 0.000 claims 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims 1
- 239000000347 magnesium hydroxide Substances 0.000 claims 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims 1
- 239000004014 plasticizer Substances 0.000 claims 1
- 239000011736 potassium bicarbonate Substances 0.000 claims 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims 1
- 235000015497 potassium bicarbonate Nutrition 0.000 claims 1
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 1
- 235000011181 potassium carbonates Nutrition 0.000 claims 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- 235000017550 sodium carbonate Nutrition 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 229940062627 tribasic potassium phosphate Drugs 0.000 claims 1
- 229940001496 tribasic sodium phosphate Drugs 0.000 claims 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Claims (6)
1. Oralno otapajući filmski pripravak, naznačen time što sadrži:
a.) preneutralizirani enterički polimer, koji je poli(etilakrilat-metakrilno kiselinski) kopolimer;
b.) najmanje jedno alkalno neutralizirajuće sredstvo; i
c.) najmanje jedno aktivno sredstvo, koji je nikotinsko ulje.
2. Filmski pripravak u skladu s patentnim zahtjevom 1, naznačen time što se navedeno alkalno neutralizirajuće sredstvo bira iz skupine koju čine natrijev karbonat, natrijev bikarbonat, kalijev karbonat, kalijev bikarbonat, dvobazni natrijev fosfat, trobazni natrijev fosfat, dvobazni kalijev fosfat, trobazni kalijev fosfat, kalcijev karbonat, magnezijev karbonat, natrijev hidroksid, magnezijev hidroksid, kalijev hidroksid, aluminijev hidroksid, te njihove smjese.
3. Filmski pripravak u skladu s patentnim zahtjevom 1 ili 2, naznačen time što navedeno alkalno neutralizirajuće sredstvo i navedeni aktivni nikotin se drži odvojeno unutar filma prije oralne primjene.
4. Filmski pripravak u skladu s patentnim zahtjevom 3, naznačen time što je film višekomponentni oralno otapajući film, koji sadrži:
(a) prvu komponentu, koja sadrži alkalno neutralizirajuće sredstvo i punilo topljivo u vodi; i
(b) drugu komponentu, koja sadrži aktivni nikotin, koji je nikotinsko ulje, preneutralizirani enterički polimer koji je poli(etilakrilat-metakrilno kiselinski) kopolimer, te plastifikator.
5. Postupak dobivanje oralno otapajući filmski pripravak, naznačen time što se sastoji u koracima:
(a) neutraliziranja enteričkog polimera koji je poli(etilakrilat-metakrilno kiselinski) kopolimer miješanjem s alkalnim neutralizirajućim sredstvomu prisutnosti otapala kako bi se dobilo smjesu polimera;
(b) dodatnog dodavanja aktivnog nikotina koji je nikotinsko ulje u smjesu polimera;
(c) lijevanja smjese polimera na pogodnu površinu; i
(d) sušenja navedene smjese polimera kako bi se dobilo polimerni film.
6. Postupak u skladu s patentnim zahtjevom 5, naznačen time što dodatno uključuje sljedeće korake:
(e) otapanja alkalnog puferskog sredstva i punila topljivog u vodi u vodi kako bi se dobilo pufersku smjesu;
(f) lijevanja puferske smjese na polimerni film, čime se dobije obloženi polimerni film; i
(g) sušenja navedenog obloženog polimernog filma.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48985503P | 2003-07-24 | 2003-07-24 | |
PCT/US2004/023719 WO2005009386A2 (en) | 2003-07-24 | 2004-07-22 | Orally dissolving films |
EP04778981.3A EP1648421B1 (en) | 2003-07-24 | 2004-07-22 | Orally dissolving films |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20171944T1 true HRP20171944T1 (hr) | 2018-01-26 |
Family
ID=34102944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20171944TT HRP20171944T1 (hr) | 2003-07-24 | 2017-12-14 | Oralno otapajući filmovi |
Country Status (24)
Country | Link |
---|---|
US (1) | US9675548B2 (hr) |
EP (2) | EP1648421B1 (hr) |
JP (4) | JP2006528636A (hr) |
CN (1) | CN100508976C (hr) |
AR (1) | AR045076A1 (hr) |
AU (2) | AU2004259006B2 (hr) |
BR (1) | BRPI0412752B8 (hr) |
CA (1) | CA2533577C (hr) |
CL (2) | CL2008002407A1 (hr) |
DK (2) | DK1648421T3 (hr) |
ES (2) | ES2466943T3 (hr) |
HK (1) | HK1169802A1 (hr) |
HR (1) | HRP20171944T1 (hr) |
HU (1) | HUE037508T2 (hr) |
LT (1) | LT1648421T (hr) |
MX (1) | MXPA06000852A (hr) |
PE (1) | PE20050496A1 (hr) |
PL (2) | PL1648421T3 (hr) |
PT (2) | PT2446881E (hr) |
RU (2) | RU2351315C2 (hr) |
SI (1) | SI1648421T1 (hr) |
TW (1) | TW200514579A (hr) |
UY (1) | UY28431A1 (hr) |
WO (1) | WO2005009386A2 (hr) |
Families Citing this family (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005046363A2 (en) | 2003-11-07 | 2005-05-26 | U.S. Smokeless Tobacco Company | Tobacco compositions |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
DE102005033943A1 (de) * | 2005-07-20 | 2007-02-22 | Hexal Ag | Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum |
DE102005058569B4 (de) * | 2005-12-08 | 2010-07-15 | Lts Lohmann Therapie-Systeme Ag | Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer |
US7810507B2 (en) | 2006-02-10 | 2010-10-12 | R. J. Reynolds Tobacco Company | Smokeless tobacco composition |
CA2640243C (en) * | 2006-02-17 | 2015-08-18 | Novartis Ag | Disintegrable oral films |
WO2008005509A2 (en) * | 2006-07-06 | 2008-01-10 | Massachusetts Institute Of Technology | Methods and compositions for altering biological surfaces |
WO2008080773A1 (de) * | 2006-12-29 | 2008-07-10 | Basf Se | Verfahren zur herstellung von festen dosierungsformen enthaltend pfropfcopolymere |
FR2912915B1 (fr) * | 2007-02-28 | 2012-11-16 | Pf Medicament | Film a desintegration rapide pour l'administration buccale de substances actives. |
EP2134321A2 (en) * | 2007-03-07 | 2009-12-23 | Novartis Ag | Orally administrable films |
WO2008135090A1 (en) * | 2007-05-07 | 2008-11-13 | Evonik Röhm Gmbh | Solid dosage forms comprising an enteric coating with accelerated drug release |
WO2009015142A2 (en) | 2007-07-23 | 2009-01-29 | R.J.Reynolds Tobacco Company | Smokeless tobacco compositions and methods for treating tobacco for use therein |
WO2009043588A2 (en) * | 2007-10-02 | 2009-04-09 | LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH | Ph regulating antibacterial films for the oral or vaginal cavity |
US9125434B2 (en) | 2007-10-11 | 2015-09-08 | Philip Morris Products S.A. | Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet |
MX2010003928A (es) * | 2007-10-11 | 2010-09-10 | Philip Morris Prod | Producto de tabaco sin humo. |
JP2009102287A (ja) * | 2007-10-19 | 2009-05-14 | Seiji Sakao | 禁煙用の辛い唐辛子 |
WO2009073190A1 (en) * | 2007-12-04 | 2009-06-11 | Swedish Match North America, Inc. | Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine |
JP2011506384A (ja) * | 2007-12-11 | 2011-03-03 | ノバルティス アーゲー | マルチゾーンフィルム |
WO2009080021A1 (en) * | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum tablet |
WO2009080022A1 (en) * | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum tablet |
WO2009099831A2 (en) * | 2008-01-31 | 2009-08-13 | Mcneil-Ppc, Inc. | Edible film-strips with modified release active ingredients |
BRPI0906648A2 (pt) * | 2008-01-31 | 2019-11-19 | Mcneil Ppc Inc | tiras de filme comestível para liberação imediata de ingredientes ativos |
MX2010008945A (es) * | 2008-02-13 | 2010-09-07 | Bayer Schering Pharma Ag | Sistema de administracion de drogas con efecto estabilizante. |
EP2263662A4 (en) * | 2008-04-15 | 2013-10-30 | Shionogi & Co | COMPOSITION OF THE FILM TYPE |
PT2364360T (pt) * | 2008-11-13 | 2017-06-27 | Nogra Pharma Ltd | Composições em sentido reverso e métodos de as fabricar e utilizar |
EP2210595A1 (en) * | 2009-01-14 | 2010-07-28 | LEK Pharmaceuticals d.d. | Active coating of pharmaceutical dosage forms |
US20100256215A1 (en) * | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Menthol-Melatonin Dissolving Film |
US20100256197A1 (en) * | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Nicotine Dissolving Film With Or Without Menthol |
AU2010248060A1 (en) * | 2009-05-12 | 2011-10-27 | Bpsi Holdings, Llc. | Enhanced moisture barrier immediate release film coating systems and substrates coated therewith |
US9017718B2 (en) * | 2009-05-21 | 2015-04-28 | Bionex Pharmaceuticals Llc | Dual and single layer dosage forms |
US8944072B2 (en) | 2009-06-02 | 2015-02-03 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US8434496B2 (en) | 2009-06-02 | 2013-05-07 | R. J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
EP2442650B1 (en) | 2009-06-12 | 2015-08-26 | Cynapsus Therapeutics Inc. | Sublingual apomorphine |
WO2010146601A1 (en) * | 2009-06-15 | 2010-12-23 | Unijules Life Sciences Ltd | Rapid dissolvable oral film for delivering herbal extract/s with or without other pharmaceutically active agents |
US20110139164A1 (en) * | 2009-12-15 | 2011-06-16 | R. J. Reynolds Tobacco Company | Tobacco Product And Method For Manufacture |
US20110220130A1 (en) * | 2009-12-15 | 2011-09-15 | John-Paul Mua | Tobacco Product And Method For Manufacture |
US20130014771A1 (en) | 2011-01-13 | 2013-01-17 | R. J. Reynolds Tobacco Company | Tobacco-derived components and materials |
US8955523B2 (en) | 2010-01-15 | 2015-02-17 | R.J. Reynolds Tobacco Company | Tobacco-derived components and materials |
US8397945B2 (en) | 2010-02-23 | 2013-03-19 | R.J. Reynolds Tobacco Company | Dispensing container |
CN103025321A (zh) * | 2010-03-23 | 2013-04-03 | 生物联合制药公司 | 快速溶解的药物释放系统 |
US9039839B2 (en) | 2010-04-08 | 2015-05-26 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material |
US10327467B2 (en) | 2010-04-14 | 2019-06-25 | Altria Client Services Llc | Preformed smokeless tobacco product |
US9402415B2 (en) | 2010-04-21 | 2016-08-02 | R. J. Reynolds Tobacco Company | Tobacco seed-derived components and materials |
CN102858327A (zh) * | 2010-04-27 | 2013-01-02 | 诺瓦提斯公司 | 口腔剂型 |
US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
US9675102B2 (en) | 2010-09-07 | 2017-06-13 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
DE102010048408A1 (de) | 2010-10-15 | 2012-04-19 | Lts Lohmann Therapie-Systeme Ag | Laminat mit verbessertem Wasserretentionsverhalten |
US20120125354A1 (en) | 2010-11-18 | 2012-05-24 | R.J. Reynolds Tobacco Company | Fire-Cured Tobacco Extract and Tobacco Products Made Therefrom |
AU2011343429B2 (en) | 2010-12-16 | 2016-10-20 | Sunovion Pharmaceuticals Inc. | Sublingual films |
US20120152265A1 (en) | 2010-12-17 | 2012-06-21 | R.J. Reynolds Tobacco Company | Tobacco-Derived Syrup Composition |
US8893725B2 (en) | 2011-01-28 | 2014-11-25 | R. J. Reynolds Tobacco Company | Polymeric materials derived from tobacco |
US9107453B2 (en) | 2011-01-28 | 2015-08-18 | R.J. Reynolds Tobacco Company | Tobacco-derived casing composition |
US9254001B2 (en) | 2011-04-27 | 2016-02-09 | R.J. Reynolds Tobacco Company | Tobacco-derived components and materials |
US9192193B2 (en) | 2011-05-19 | 2015-11-24 | R.J. Reynolds Tobacco Company | Molecularly imprinted polymers for treating tobacco material and filtering smoke from smoking articles |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
EP2765989B1 (en) * | 2011-10-13 | 2016-04-13 | Jaleva Pharmaceuticals LLC | Methods and compositions for rapid transbuccal delivery of active agents |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US20130125907A1 (en) | 2011-11-17 | 2013-05-23 | Michael Francis Dube | Method for Producing Triethyl Citrate from Tobacco |
US10881132B2 (en) | 2011-12-14 | 2021-01-05 | R.J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
EP2827727B1 (en) | 2012-03-19 | 2021-10-13 | R. J. Reynolds Tobacco Company | Method for treating an extracted tobacco pulp and tobacco products made therefrom |
US10799451B2 (en) * | 2012-03-27 | 2020-10-13 | Nicoccino Ab | Nicotine formulation |
US9822257B2 (en) | 2012-07-23 | 2017-11-21 | Crayola Llc | Dissolvable films and methods of using the same |
EP2906210A4 (en) * | 2012-10-12 | 2016-06-08 | Jaleva Pharmaceuticals Llc | METHOD FOR PRODUCING RESIN TINCTURES |
EP2925273A4 (en) | 2012-11-28 | 2016-08-31 | Jaleva Pharmaceuticals Llc | DOPPELKAMMERAPPLIKATOR |
US20140166028A1 (en) * | 2012-12-14 | 2014-06-19 | Richard C. Fuisz | Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor or Smoke Producing Device Through Use of an Absorption Conditioning Unit |
US20140166027A1 (en) * | 2012-12-14 | 2014-06-19 | Richard C. Fuisz | Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor Producing Device Through Use of an Absorption Conditioning Unit |
US9289011B2 (en) | 2013-03-07 | 2016-03-22 | R.J. Reynolds Tobacco Company | Method for producing lutein from tobacco |
EP2968196A2 (en) | 2013-03-14 | 2016-01-20 | Altria Client Services LLC | Soft oral product |
US20140275148A1 (en) * | 2013-03-15 | 2014-09-18 | Novus Pharma LLC | Orally administrable, self-supporting dissolving film dosage forms |
US10799548B2 (en) * | 2013-03-15 | 2020-10-13 | Altria Client Services Llc | Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products |
WO2014188079A1 (en) * | 2013-05-23 | 2014-11-27 | Åbo Akademi University | Printed dosage forms |
US20150034109A1 (en) | 2013-08-02 | 2015-02-05 | R.J. Reynolds Tobacco Company | Process for Producing Lignin from Tobacco |
US11503853B2 (en) | 2013-09-09 | 2022-11-22 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition incorporating a botanical material |
WO2015038400A1 (en) * | 2013-09-11 | 2015-03-19 | 3M Innovative Properties Company | Oral compositions |
US10357054B2 (en) | 2013-10-16 | 2019-07-23 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
US20150147555A1 (en) * | 2013-11-23 | 2015-05-28 | Orahealth Corporation | Multilayer mucoadhering patch with a nonadhering layer comprising casein |
CA2931547A1 (en) | 2013-12-09 | 2015-06-18 | Durect Corporation | Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same |
WO2015103033A1 (en) | 2013-12-31 | 2015-07-09 | Johnson & Johnson Consumer Companies, Inc. | Process for forming a shaped film product |
US20150182992A1 (en) | 2013-12-31 | 2015-07-02 | Johnson & Johnson Consumer Companies, Inc. | Process for forming a multilayered shaped film product |
JP6517216B2 (ja) | 2013-12-31 | 2019-05-22 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド | 多層賦形フィルム製品を形成するための単一パス方法 |
US9265284B2 (en) | 2014-01-17 | 2016-02-23 | R.J. Reynolds Tobacco Company | Process for producing flavorants and related materials |
US20170360942A1 (en) * | 2014-12-09 | 2017-12-21 | Monosol Rx, Llc | Linear polysaccharide based film products |
DE102015201871B4 (de) * | 2015-02-03 | 2018-04-05 | Ferton Holding S.A. | Verwendung eines Pulvers als Mittel zur Pulverstrahlbearbeitung in einem Pulverstrahlgerät und Verfahren zur Reinigung von Zähnen |
US10881133B2 (en) | 2015-04-16 | 2021-01-05 | R.J. Reynolds Tobacco Company | Tobacco-derived cellulosic sugar |
WO2016172095A1 (en) | 2015-04-21 | 2016-10-27 | Cynapsus Therapeutics, Inc. | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa |
US20170059554A1 (en) | 2015-09-02 | 2017-03-02 | R. J. Reynolds Tobacco Company | Method for monitoring use of a tobacco product |
ITUB20153446A1 (it) * | 2015-09-07 | 2017-03-07 | Pharmafilm Srl | Film orodispersibili a rapida disgregazione per uso terapeutico o alimentare |
US10869497B2 (en) | 2015-09-08 | 2020-12-22 | R.J. Reynolds Tobacco Company | High-pressure cold pasteurization of tobacco material |
US10532046B2 (en) | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
US10499684B2 (en) | 2016-01-28 | 2019-12-10 | R.J. Reynolds Tobacco Company | Tobacco-derived flavorants |
US11154087B2 (en) | 2016-02-02 | 2021-10-26 | R.J. Reynolds Tobacco Company | Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds |
CN109475508A (zh) * | 2016-06-07 | 2019-03-15 | 阿瑞迪思医药品股份有限责任公司 | 具有增强的热稳定性的含有生物活性材料的速溶薄膜的制备方法 |
IL247161A0 (en) * | 2016-08-08 | 2016-12-29 | Rubin Yoram | Fast-dissolving adhesive films for the treatment of oral conditions |
US11091446B2 (en) | 2017-03-24 | 2021-08-17 | R.J. Reynolds Tobacco Company | Methods of selectively forming substituted pyrazines |
JP7278281B2 (ja) | 2017-12-08 | 2023-05-19 | フェルティン ファルマ アー/エス | ニコチン錠 |
US20190307082A1 (en) | 2018-04-05 | 2019-10-10 | R.J. Reynolds Tobacco Company | Oriental tobacco production methods |
WO2019204708A1 (en) * | 2018-04-21 | 2019-10-24 | Quest Products, Llc | Bilayer adhering lozenge effective to mask undesirable flavor |
CN112384504A (zh) | 2018-06-15 | 2021-02-19 | R.J.雷诺兹烟草公司 | 烟碱的纯化 |
WO2019244176A1 (en) * | 2018-06-23 | 2019-12-26 | Strides Shasun Limited | Stable nicotine lozenges |
US11235013B2 (en) | 2018-09-04 | 2022-02-01 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
JP7361547B2 (ja) | 2019-09-10 | 2023-10-16 | 三菱電機ビルソリューションズ株式会社 | ロボットシステム |
WO2021177941A1 (en) * | 2020-03-03 | 2021-09-10 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
MX2023012458A (es) * | 2021-04-22 | 2024-01-08 | Nicoventures Trading Ltd | Peliculas de disolucion oral. |
WO2024037043A1 (zh) * | 2023-04-28 | 2024-02-22 | 深圳华宝协同创新技术研究院有限公司 | 用于口腔粘膜的包含尼古丁的薄膜组合物 |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5288498A (en) | 1985-05-01 | 1994-02-22 | University Of Utah Research Foundation | Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments |
JPH0729915B2 (ja) | 1986-02-01 | 1995-04-05 | 帝國製薬株式会社 | シ−ト状口腔内貼付剤 |
JPS62223112A (ja) * | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
DE3827561C1 (hr) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
DE4310012A1 (de) | 1993-03-27 | 1994-09-29 | Roehm Gmbh | Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung |
EP0708627B1 (en) | 1993-07-09 | 2000-02-02 | Cygnus, Inc. | Method and device for providing nicotine replacement therapy transdermally/transbuccally |
GB9405137D0 (en) | 1994-03-16 | 1994-04-27 | Xaar Ltd | Improvements relating to pulsed droplet deposition apparatus |
AU2703795A (en) | 1994-06-23 | 1996-01-19 | Procter & Gamble Company, The | Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine |
US5508276A (en) * | 1994-07-18 | 1996-04-16 | Eli Lilly And Company | Duloxetine enteric pellets |
WO1996022083A1 (en) | 1995-01-19 | 1996-07-25 | Cygnus, Inc. | POLYISOBUTYLENE ADHESIVES CONTAINING HIGH Tg TACKIFIER FOR TRANSDERMAL DEVICES |
JPH08245423A (ja) * | 1995-03-06 | 1996-09-24 | Shionogi & Co Ltd | 水系腸溶性コーティング液 |
HU224035B1 (hu) * | 1996-05-13 | 2005-05-30 | Novartis Consumer Health S.A. | Bukkális adagolórendszer |
US6623759B2 (en) | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
DE19626045C2 (de) * | 1996-06-28 | 1998-12-03 | Klinge Co Chem Pharm Fab | Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben |
GB9614902D0 (en) | 1996-07-16 | 1996-09-04 | Rhodes John | Sustained release composition |
DE19646392A1 (de) | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
DE19653605C2 (de) | 1996-12-20 | 2002-11-28 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems |
WO1998058947A1 (en) * | 1997-06-25 | 1998-12-30 | Pfizer Inc. | Dipeptide derivatives as growth hormone secretagogues |
US6197331B1 (en) * | 1997-07-24 | 2001-03-06 | Perio Products Ltd. | Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity |
US20030176467A1 (en) | 1997-09-25 | 2003-09-18 | Sven Andersson | Nicotine compositions |
JP3460538B2 (ja) | 1997-10-08 | 2003-10-27 | 救急薬品工業株式会社 | 速溶性フィルム製剤 |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
EP1357109B1 (en) | 1998-06-18 | 2008-07-23 | F. Hoffmann-La Roche Ag | Process for aryl alkyl sulfide |
US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
US6596298B2 (en) | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
ES2237415T5 (es) | 1999-01-14 | 2008-12-16 | Noven Pharmaceuticals, Inc. | Composiciones dermicas. |
US20030170195A1 (en) | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
US6248760B1 (en) | 1999-04-14 | 2001-06-19 | Paul C Wilhelmsen | Tablet giving rapid release of nicotine for transmucosal administration |
US6264981B1 (en) | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
US6420473B1 (en) | 2000-02-10 | 2002-07-16 | Bpsi Holdings, Inc. | Acrylic enteric coating compositions |
US7067116B1 (en) | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
KR100452972B1 (ko) | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | 경피투여용 하이드로젤 조성물 |
JP4555436B2 (ja) | 2000-06-29 | 2010-09-29 | 富士通株式会社 | 薄膜樹脂基板への樹脂モールド方法及び高周波モジュール |
DE10032456A1 (de) | 2000-07-04 | 2002-01-31 | Lohmann Therapie Syst Lts | Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen |
EP1346305A4 (en) | 2000-11-22 | 2005-04-06 | Lawrence Ausubel | SYSTEM AND METHOD FOR DYNAMIC AUCTION WITH PACKAGE SUBMISSION |
US20020131990A1 (en) | 2000-11-30 | 2002-09-19 | Barkalow David G. | Pullulan free edible film compositions and methods of making the same |
US6479076B2 (en) | 2001-01-12 | 2002-11-12 | Izhak Blank | Nicotine delivery compositions |
DE10110391A1 (de) | 2001-03-03 | 2002-09-26 | Lohmann Therapie Syst Lts | Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff |
PL364621A1 (en) * | 2001-03-26 | 2004-12-13 | Smithkline Beecham Corporation | Nicotine-containing oral dosage form |
NZ530439A (en) | 2001-04-20 | 2004-11-26 | Lavipharm Lab Inc | Intraoral delivery of nicotine for smoking cessation |
JP2004534822A (ja) * | 2001-06-22 | 2004-11-18 | ファイザー・プロダクツ・インク | 低溶解度および/または酸感受性の薬剤と中和された酸性ポリマーとを含む医薬組成物 |
WO2003003957A1 (en) | 2001-07-06 | 2003-01-16 | Lavipharm Laboratories Inc. | Quick dissolving oral mucosal drug delivery device with moisture barrier coating |
DE10141652B4 (de) | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
US20030092724A1 (en) | 2001-09-18 | 2003-05-15 | Huaihung Kao | Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic |
JP5089840B2 (ja) * | 2001-09-25 | 2012-12-05 | 救急薬品工業株式会社 | ニコチン含有フィルム製剤 |
BR0212950A (pt) * | 2001-09-28 | 2004-10-26 | Mcneil Ppc Inc | Formas de dosagens compósitas tendo uma porção inserida |
US7425292B2 (en) * | 2001-10-12 | 2008-09-16 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
US20040037879A1 (en) * | 2001-11-02 | 2004-02-26 | Adusumilli Prasad S. | Oral controlled release forms useful for reducing or preventing nicotine cravings |
MXPA02011337A (es) | 2001-11-16 | 2003-05-26 | Nat Starch Chem Invest | Peliculas que contienen almidon. |
US20030099691A1 (en) | 2001-11-16 | 2003-05-29 | Susan Lydzinski | Films containing starch |
DE10224612A1 (de) * | 2002-06-04 | 2003-12-24 | Lohmann Therapie Syst Lts | Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung |
US20040013752A1 (en) | 2002-07-05 | 2004-01-22 | Wolfson Philip E. | Buccal and sublingual mucosally absorbed herbal compositions for relieving nicotine withdrawal symptoms and craving for nicotine and nicotine containing substances |
US8268352B2 (en) | 2002-08-05 | 2012-09-18 | Torrent Pharmaceuticals Limited | Modified release composition for highly soluble drugs |
US8216609B2 (en) | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
US20030049307A1 (en) | 2002-08-15 | 2003-03-13 | Gyurik Robert J. | Pharmaceutical composition |
DE10256775A1 (de) | 2002-12-05 | 2004-06-24 | Lts Lohmann Therapie-Systeme Ag | Filmförmige Zubereitungen zur transmucosalen Verabreichung von Nicotin, sowie Verfahren zu deren Herstellung |
NO346973B1 (en) | 2002-12-20 | 2023-03-20 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
US20040208931A1 (en) | 2002-12-30 | 2004-10-21 | Friend David R | Fast dissolving films for oral administration of drugs |
WO2005004989A2 (en) | 2003-07-01 | 2005-01-20 | Todd Maibach | Film comprising therapeutic agents |
DE10338544B4 (de) | 2003-08-19 | 2017-08-31 | Janssen Pharmaceutica N.V. | Buccale Formulierungen des Galanthamins und deren Anwendungen |
KR20050048056A (ko) | 2003-11-18 | 2005-05-24 | (주)케이비피 | 경구용 소모 필름 조성물 |
DE10354894A1 (de) | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
US20050181050A1 (en) | 2004-01-28 | 2005-08-18 | Collegium Pharmaceutical, Inc. | Dosage forms using drug-loaded ion exchange resins |
WO2005115336A2 (en) | 2004-05-15 | 2005-12-08 | Collegium Pharmaceutical, Inc. | Sprayable formulations for the treatment of acute inflammatory skin conditions |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US20060046969A1 (en) | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Antibacterial compositions for drug administration |
EP1789075A4 (en) | 2004-08-25 | 2009-07-01 | Uab Research Foundation | ABSORPTION ENHANCER FOR DRUG ADMINISTRATION |
US20060046962A1 (en) | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Absorption enhancers for drug administration |
ES2596809T3 (es) | 2004-10-08 | 2017-01-12 | Noven Pharmaceuticals, Inc. | Dispositivo de administración transdérmica de fármacos que incluye un refuerzo oclusivo |
CA2583101A1 (en) | 2004-10-15 | 2006-04-20 | Pfizer Products Inc. | Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline |
GB0508306D0 (en) | 2005-04-25 | 2005-06-01 | Bioprogress Technology Ltd | Nicotine dosage forms |
JP5000932B2 (ja) | 2005-06-21 | 2012-08-15 | 日東電工株式会社 | ニコチン含有経皮吸収製剤 |
CA2640243C (en) | 2006-02-17 | 2015-08-18 | Novartis Ag | Disintegrable oral films |
US20070269386A1 (en) | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
JP5502494B2 (ja) | 2007-01-22 | 2014-05-28 | ターガセプト・インコーポレイテッド | メタニコチンアナログの鼻腔内、バッカル、または舌下投与 |
FR2912915B1 (fr) | 2007-02-28 | 2012-11-16 | Pf Medicament | Film a desintegration rapide pour l'administration buccale de substances actives. |
EP2134321A2 (en) | 2007-03-07 | 2009-12-23 | Novartis Ag | Orally administrable films |
US20080286340A1 (en) | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered nicotine containing products |
US20080292683A1 (en) | 2007-05-24 | 2008-11-27 | Monosolrx, Llc. | Film shreds and delivery system incorporating same |
KR101405930B1 (ko) * | 2007-07-05 | 2014-06-12 | 엘지전자 주식회사 | 식기 세척기의 제어방법 |
US20090081294A1 (en) | 2007-09-26 | 2009-03-26 | Gin Jerry B | Sustained release dosage form for lubricating an oral cavity |
KR100905027B1 (ko) | 2007-10-03 | 2009-06-30 | (주)씨엘팜 | 식용 필름 |
WO2009045022A2 (en) | 2007-10-03 | 2009-04-09 | C.L. Pharm | Edible film |
WO2009073190A1 (en) | 2007-12-04 | 2009-06-11 | Swedish Match North America, Inc. | Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine |
JP2011506384A (ja) | 2007-12-11 | 2011-03-03 | ノバルティス アーゲー | マルチゾーンフィルム |
RU2011119494A (ru) | 2008-10-14 | 2012-11-27 | Макнейл Аб | Многокомпонентная интраоральная лекарственная форма препарата и ее применение |
US20100247586A1 (en) | 2009-03-27 | 2010-09-30 | Andreas Hugerth | Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties |
KR101074271B1 (ko) | 2009-06-25 | 2011-10-17 | (주)차바이오앤디오스텍 | 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름 |
PT2519225E (pt) | 2009-12-30 | 2015-07-27 | Novartis Ag | Tiras finas de nicotina extrudidas por fusão |
CN102858327A (zh) | 2010-04-27 | 2013-01-02 | 诺瓦提斯公司 | 口腔剂型 |
KR20140016239A (ko) | 2010-09-24 | 2014-02-07 | 넥스메드 홀딩스 인코포레이티드 | 협측을 통한 향상된 약물 전달 시스템 및 조성물 |
-
2004
- 2004-07-22 AR ARP040102603A patent/AR045076A1/es unknown
- 2004-07-22 RU RU2006105630/15A patent/RU2351315C2/ru active
- 2004-07-22 PT PT121523013T patent/PT2446881E/pt unknown
- 2004-07-22 LT LTEP04778981.3T patent/LT1648421T/lt unknown
- 2004-07-22 BR BRPI0412752A patent/BRPI0412752B8/pt active IP Right Grant
- 2004-07-22 CN CNB2004800213483A patent/CN100508976C/zh active Active
- 2004-07-22 US US10/565,706 patent/US9675548B2/en active Active
- 2004-07-22 CA CA2533577A patent/CA2533577C/en active Active
- 2004-07-22 ES ES12152301.3T patent/ES2466943T3/es active Active
- 2004-07-22 AU AU2004259006A patent/AU2004259006B2/en active Active
- 2004-07-22 PL PL04778981T patent/PL1648421T3/pl unknown
- 2004-07-22 PL PL12152301T patent/PL2446881T3/pl unknown
- 2004-07-22 JP JP2006521266A patent/JP2006528636A/ja active Pending
- 2004-07-22 PT PT47789813T patent/PT1648421T/pt unknown
- 2004-07-22 EP EP04778981.3A patent/EP1648421B1/en active Active
- 2004-07-22 DK DK04778981.3T patent/DK1648421T3/en active
- 2004-07-22 UY UY28431A patent/UY28431A1/es unknown
- 2004-07-22 DK DK12152301.3T patent/DK2446881T3/da active
- 2004-07-22 HU HUE04778981A patent/HUE037508T2/hu unknown
- 2004-07-22 EP EP12152301.3A patent/EP2446881B1/en active Active
- 2004-07-22 MX MXPA06000852A patent/MXPA06000852A/es unknown
- 2004-07-22 TW TW093121830A patent/TW200514579A/zh unknown
- 2004-07-22 ES ES04778981.3T patent/ES2654062T3/es active Active
- 2004-07-22 PE PE2004000696A patent/PE20050496A1/es active IP Right Grant
- 2004-07-22 WO PCT/US2004/023719 patent/WO2005009386A2/en active Application Filing
- 2004-07-22 SI SI200432422T patent/SI1648421T1/en unknown
-
2008
- 2008-01-14 RU RU2008101513/15A patent/RU2008101513A/ru not_active Application Discontinuation
- 2008-08-14 CL CL2008002407A patent/CL2008002407A1/es unknown
- 2008-08-14 CL CL2008002406A patent/CL2008002406A1/es unknown
-
2010
- 2010-02-25 JP JP2010040716A patent/JP5378270B2/ja active Active
- 2010-09-28 AU AU2010224456A patent/AU2010224456B9/en active Active
- 2010-10-08 JP JP2010228787A patent/JP5038477B2/ja active Active
-
2011
- 2011-08-08 JP JP2011172951A patent/JP5572133B2/ja active Active
-
2012
- 2012-10-22 HK HK12110485.7A patent/HK1169802A1/xx unknown
-
2017
- 2017-12-14 HR HRP20171944TT patent/HRP20171944T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20171944T1 (hr) | Oralno otapajući filmovi | |
JP4914552B2 (ja) | アクリル系の腸溶性コーティング組成物 | |
KR102164600B1 (ko) | 칼슘 실리케이트를 포함하는 서방형 필름 코팅 및 이로 코팅된 기질 | |
US8647645B2 (en) | Enhanced moisture barrier immediate release film coating systems and substrates coated therewith | |
US4521551A (en) | Denture fixative composition containing partially neutralized copolymers of maleic acid or anhydride and alkyl vinyl ethers which are optionally partially crosslinked | |
JPH0586228B2 (hr) | ||
HRP20030082A2 (en) | Hydrogel-driven drug dosage form | |
JP2016513736A5 (hr) | ||
KR20040066177A (ko) | 친수성 거대분자의 경구 생체이용률을 증가시키기 위한제형 및 투여 형태 | |
US20080241238A1 (en) | Controlled Release Coated Tablets Having Prolonged Gastric Retention | |
KR20080048461A (ko) | 위장체류 제제 및 이의 제조 방법 | |
WO2014154029A1 (zh) | 复合骨架材料及其药物组合物 | |
JP2016535030A5 (hr) | ||
JP2505922B2 (ja) | セルロ―ス系コ―テイング | |
SE8300577L (sv) | Overdrag som tillforsekrar reglerad avgivning av akriva bestandsdelar fran biologiskt aktiva blandningar, i synnerhet farmaceutiska beredningar, jemte sett att framstella biologiskt aktiva blandningar med reglerad .... | |
CN101982199A (zh) | 含有对酸不稳定的生理活性化合物的制剂组合物及其制法 | |
CA2470463A1 (en) | Tooth whitening products and methods of making the same | |
EP1368002A2 (fr) | Procede de fabrication d'un comprime flottant incluant de l'alfuzosine | |
US9095577B2 (en) | Stabilized amine-containing actives in oral film compositions | |
JP2012519726A (ja) | 治療薬のパルス放出組成物 | |
JPH10273436A (ja) | 咀嚼用ソフトカプセル剤 | |
RU2018137590A (ru) | Фармацевтические композиции для производного n-пропаргиламина | |
WO2010093020A1 (ja) | 硬カプセル | |
RU2117476C1 (ru) | Таблетка ранитидина с покрытием, содержащим гидроксипропилметилцеллюлозу, и способ нанесения такого покрытия | |
HU230402B1 (hu) | Bélben oldódó akril bevonó készítmények |